Longevity Startup to Conduct Human Trials for Anti-Aging Gene Therapy
Life Biosciences, a Boston-based biotech company founded by Harvard professor David Sinclair, is set to conduct human clinical trials for a cellular reprogramming treatment targeting aging.
The treatment aims to rejuvenate cells without altering their core function, potentially addressing age-related diseases such as Alzheimer's, Type 2 diabetes, and Parkinson's.
This potential breakthrough for longevity science also raises a host of ethical concerns, from overpopulation to "hyper-beautification."
The company's founder, David Sinclair, is a professor at Harvard Medical School and Life Biosciences was founded in 2017.
Author's summary: Life Biosciences conducts human trials for anti-aging therapy.
- Company: Life Biosciences
- Founder: David Sinclair
- Location: Boston
- Year founded: 2017
More News
- Florence + The Machine - Everybody Scream Review
- 'Thief VR: Legacy of Shadow' Comes to All Major VR Headsets in December, New Gameplay Here
- Over 580,000 Blood Pressure Medication Bottles Recalled, FDA Reports
- Ayuba Sylvester James: “For MCP to Rise, Chakwera Must Fall” - Malawi Nyasa Times - News from Malawi about Malawi
- Bitches in Stitches: Northern Quarter's new all-female comedy shows - Mancunian Matters
- GPSC Recruitment 2025: Registration Process For 44 Assistant Professor Ends Soon; Check Age Limit Here
- From Trump, With Impunity